Abstract

Olfactory impairment is present in up to 90% of patients with Alzheimer’s disease (AD) and is present in certain cases of mild cognitive impairment (MCI), a transient phase between normal aging and dementia. Subjects affected by MCI have a higher risk of developing dementia compared to the general population, and studies have found that olfactory deficits could be an indicator of whether such a conversion might happen. Following these assumptions, aim of this study was to investigate olfactory perception in MCI patients. We recruited 12 MCI subjects (mean age 70 ± 6.7 years) through the Alzheimer Assessment Unit (UVA Unite) of ASL Lecce (Italy), and 12 healthy geriatric volunteers (HS) as the control group (mean age 64 ± 6.0 years), all of whom were first evaluated via a panel of neuropsychological tests. Subjects were asked to perform an olfactory recognition task involving two scents: rose and eucalyptus, administrated in the context of an oddball task during EEG recordings. Olfactory event-related potential (OERP) components N1 and Late Positive Potential (LPC) were then analyzed as measures of the sensorial and perceptive aspects of the olfactory response, respectively. It was determined that, in the MCI group, both the N1 and LPC components were significantly different compared to those of the HS group during the execution of the oddball task. In particular, the N1 amplitude, was reduced, while the LPC amplitude was increased, indicating that a degree of perceptive compensation can occur when sensorial function is impaired. Further, a correlation analysis, involving OERP components and neuropsychological battery scores, indicated that impairment of olfactory perception may share common pathways with impairments of the spatial system and long-term memory processing.

Highlights

  • Mild cognitive impairment (MCI) refers to a clinical state marking the transitional phase between normal cognitive function and pathogenic Alzheimer’s disease (AD) (Gauthier et al, 2006), characterized by deficits relating to memory, attention span, language, visuospatial ability, the speed of perception, and the performance of executive functions (Saunders and Summers, 2010; Petersen, 2011)

  • A study conducted using the University of Pennsylvania Smell Identification Test (UPSIT), a behavioral assessment of olfactory memory, concluded that olfactory deficits may be a useful biomarker of AD progression (Kirkpatrick et al, 2006), while an MRI study of the olfactory bulb and olfactory tract atrophy in mild cognitive impairment (MCI) and AD patients has indicated that olfactory bulb atrophy could be a surrogate biomarker of AD (Graves et al, 1999)

  • Our analysis indicated that there were no significant differences in the Late Positive Component (LPC) components elicited by the eucalyptus scent

Read more

Summary

INTRODUCTION

Mild cognitive impairment (MCI) refers to a clinical state marking the transitional phase between normal cognitive function and pathogenic Alzheimer’s disease (AD) (Gauthier et al, 2006), characterized by deficits relating to memory, attention span, language, visuospatial ability, the speed of perception, and the performance of executive functions (Saunders and Summers, 2010; Petersen, 2011). Patients with naMCI do not show memory impairment, but do display loss in other cognitive domains and have a higher risk of developing the disease in other dementia forms (e.g., Lewy Body dementia) (Csukly et al, 2016) Both categories can be further assessed to single-domain and multi-domain according to the involvement of one or more cognitive deficit (memory, language, visuospatial ability, speed of mental processing, or executive function) (Libon et al, 2010; Albert et al, 2011). The impairment of neuropsychological and psychophysiological functions can be assessed at behavioral level through neuropsychological tests and can be related with data obtained through different neuroimaging tools (MRI, PET, or SPECT) (Albert et al, 2011) One of these clinical aspects is the atrophy of the hippocampus and the entorhinal cortex, structures involved in the sense of smell (Chételat et al, 2005; Devanand et al, 2007; Shi et al, 2009; Mueller et al, 2010). This method allowed for the blind presentation of smells (Invitto et al, 2014, 2017b)

MATERIALS AND METHODS
RESULTS
DISCUSSION AND CONCLUSION

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.